Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New contact lenses promise more comfort for aging eyes

NCT ID NCT07586982

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether Total30 multifocal toric contact lenses are more comfortable and provide better vision than current lenses for people with presbyopia (age-related blurry near vision). 32 adults aged 40 and older who already wear toric contacts will try the new lenses for one month. Researchers will measure comfort and dryness using questionnaires and vision tests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Total30 multifocal toric contact lenses
What this could lead to
If successful, this could show that Total30 lenses provide better comfort and vision for people with presbyopia who already wear toric contacts.
What could go wrong
This is a small, early-stage study with only 32 participants, so results may not apply to everyone. Comfort is subjective and may not improve for all.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 32 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults, ≥40-year-old, CL wearers with best-corrected 20/20 distance visual acuity or better. * Requiring +0.75 ADD or more at standard near distance of 40 cm. * Participants will be required to have worn reusable silicone hydrogel toric CLs in the past year and still at a minimum wearing the CLs occasionally without having significant discomfort or dryness. * All participants will be required to have a CLDEQ-8 score \<12. * Participants will be required to be able to wear Total 30MFT CLs (presbyopic plus astigmatism both ≥0.75D OD and OS). * Astigmatism ranging from 0.75 D to 2.50 D in each eye. * Participants will be required to wear the study CLs for ≥13 hours each day with no overnight wear. * Willing to wear study CLs for ≥16 hours on the Day 1 (1st full day), Day 14, and Day 29 when responses will be collected via text message. * Participants will be willing to wear the CL every day of the week. * Participants will be required to provide a glasses prescription that is less than 3 years old. * Visual acuity with habitual reusable silicone hydrogel toric CLs is 20/25 or better in each eye. Exclusion Criteria: * Have worn Total30 MFT in the past * Are past rigid CL wearers * Are currently wearing monovision CLs * Have a history of being diagnosed with dry eye or ocular allergies * Have known systemic health conditions that are thought to alter tear film physiology * Have a history of viral eye disease * Have a history of ocular surgery * Have a history of severe ocular trauma * Have a history of corneal dystrophies or degenerations * Have active ocular infection or inflammation * Are currently using isotretinoin-derivatives or ocular medications * Are pregnant or breast feeding

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Astigmatism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Southern College of Optometry

    RECRUITING

    Memphis, Tennessee, 38104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.